ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

Obituary: Daniel Nathans, 71, Won Nobel For Use of Restriction Enzyme

November 19, 1999

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980